Univariate analysis adjusted by risk factor

Risk Factor

Patients with aGVHD and risk factor

OR

95% CI

p-value

Peripheral blood

23

6.25

2.39 - 16.28

0.001

Bone marrow

1

0.9

0.90 - 9.04

0.7

umbilical cord

3

0.15

0.45 - 0.53

0.001

Total body irradiation

10

1.96

0.76 - 5.03

0.12

Infection 3 months prior to allogeneic transplant

8

2.4

0.84 - 6.78

0.84

HLA-matched unrelated

1

1.1

0.20 - 6.06

0.64

HLA-non-matched unrelated

4

1.66

0.44 - 6.19

0.32

Donor/recipient Female/male

9

2.58

0.94 - 7.10

0.05

Bacteremia within the first 7 days post-transplant, n

12

1.38

0.57 - 3.35

0.3

CMV infection in the recipient

4

4.11

0.85 - 19.68

0.03

PB > BM

20

12.3

4.46 - 33.92

0.001

Cell dose > 8.3 × 106/kg

3

7.1

1.09 - 46.24

0.05